ACHV
Achieve Life Sciences Hits Stride with Landmark NDA Submission and FDA Priority Voucher
Achieve Life Sciences is making headlines in the medical community with its latest achievements. The company has recently submitted a new drug application (NDA) for cytisinicline, a novel treatment for nicotine dependence, which marks a significant milestone in the development of this life-changing medication. According to Rick Stewart, President and